VEGFA and retinopathy of prematurity: As to efficacy compared to laser therapy, anti-VEGF agents as primary treatments had potential advantages for the eyes with posterior ROP (zone I type 1 ROP and A-ROP), and for the eyes with zone II type 1 ROP, anti-VEGF agents therapy showed similar efficacy; however, there was a significantly higher rate of reactivation [14].